SIGA Technologies Inc. (SIGA) News
Filter SIGA News Items
SIGA News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest SIGA News From Around the Web
Below are the latest news stories about SIGA TECHNOLOGIES INC that investors may wish to consider to help them evaluate SIGA as an investment opportunity.
Investors in SIGA Technologies (NASDAQ:SIGA) have unfortunately lost 44% over the last yearPassive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you... |
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023- In Third Quarter, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - In October, Joint Procurement Framework Contract was signed by European Commission with Anticipated Initial Orders by Participating Countries of Approximately $18 Million for Oral TPOXX® (Tecovirimat) - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-s |
SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial ResultsNEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, November 7th, 2023. Participating on the call will be Phil Gomez, Chief Executive Officer, Dennis Hruby, Chief Scientific Officer, Dr. Jay Varma, Chief Medical Officer and Daniel Luckshire, Chief Financial Officer. A live webcast of the |
SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating CountriesNEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced the creation by the European Commission’s DG HERA (Health Emergency Preparedness and Response Authority) of a joint procurement mechanism under which 13 participating countries from the European Union (EU) and the European Free Trade Association (EFTA) can efficiently order oral TPOXX. Based on commitments from |
The Zacks Analyst Blog Highlights Virco, G-III Apparel, SIGA Technologies, Lantronix and DuolingoVirco, G-III Apparel, SIGA Technologies, Lantronix and Duolingo are included in this Analyst Blog. |
SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical OfficerNEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executive Vice President and Chief Medical Officer (CMO). He will also continue to serve as a director of the SIGA Board of Directors. “As SIGA has worked to support the global response to the MPOX outbreak and as we continue to expand our role in planning for the preve |
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023- In July, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2023. “SIGA’s second quarter financial results reflect the continuation of international sales activity that |
Why Is SIGA Technologies (SIGA) Stock Up 31% Today?SIGA Technologies (SIGA) stock is soaring higher on Friday after the pharmaceutical company secured a #138 million government order. |
Why Is Sleep Number (SNBR) Stock Down 25% Today?Sleep Number (SNBR) stock is falling on Friday following the release of a mixed Q2 earnings report and the addition of a new CFO. |
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 43% Today?Tonix Pharmaceuticals (TNXP) stock is taking a beating on Friday after the company announced a $7 million public stock offering. |